Skip to main content
EWTX logo

EWTX · Edgewise Therapeutics, Inc. · Executive Compensation

Track EWTX — free
$39.91 -1.27 (-3.07%) At close · Nov 20
Market Cap
$4.37B
Shares
109.48M
Volume · Nov 20 1.19M Avg daily vol (3M) 1.53M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Christopher Martin Appointed 2025-11-20
Michael Carruthers
“Mr. Carruthers' decision was not the result of any disagreement with the Company.”
Retired 2025-11-10
Michael Nofi Appointed 2025-11-10
Behrad Derakhshan Appointed 2025-01-22
Arlene Morris Appointed 2024-05-07
Kenneth Harrison, Ph.D.
“Dr. Harrison’s resignation was not the result of any disagreement with management or the Board.”
Resigned 2023-06-22
Dr. Jonathan Fox Appointed 2023-03-06

Leadership

Key facts CIK 1710072 CUSIP 28036F105 13F (30d) 260 filings 237 filers Visit website Investor relations